Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 25;8(1):155-167.
doi: 10.14338/IJPT-20-00069.1. eCollection 2021 Summer.

Proton Radiotherapy to Reduce Late Complications in Childhood Head and Neck Cancers

Affiliations

Proton Radiotherapy to Reduce Late Complications in Childhood Head and Neck Cancers

Michael T Spiotto et al. Int J Part Ther. .

Abstract

In most childhood head and neck cancers, radiotherapy is an essential component of treatment; however, it can be associated with problematic long-term complications. Proton beam therapy is accepted as a preferred radiation modality in pediatric cancers to minimize the late radiation side effects. Given that childhood cancers are a rare and heterogeneous disease, the support for proton therapy comes from risk modeling and a limited number of cohort series. Here, we discuss the role of proton radiotherapy in pediatric head and neck cancers with a focus on reducing radiation toxicities. First, we compare the efficacy and expected toxicities in proton and photon radiotherapy for childhood cancers. Second, we review the benefit of proton radiotherapy in reducing acute and late radiation toxicities, including risks for secondary cancers, craniofacial development, vision, and cognition. Finally, we review the cost effectiveness for proton radiotherapy in pediatric head and neck cancers. This review highlights the benefits of particle radiotherapy for pediatric head and neck cancers to improve the quality of life in cancer survivors, to reduce radiation morbidities, and to maximize efficient health care use.

Keywords: neoplasms, radiation-induced; proton therapy; radiotherapy; radiotherapy, intensity-modulated.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Steven J. Frank, M.D., is an Associate Editor of the International Journal of Particle Therapy. Dr Frank reports grants and personal fees from Hitachi. Outside the submitted work, Dr Frank is a cofounder of C4 Imaging, LLC, for which he reports grants and personal fees, and he reports personal fees from Varian; grants from Eli Lilly, Elekta, and Breakthrough Chronic Care; and personal fees from Augmenix and the National Comprehensive Cancer Center (NCCN). The authors have no additional conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
Comparison of IMPT and VMAT dose distributions. IMPT (left) and VMAT (right) plans with isodose line plans (right). Isodose lines: green: 5640 cGy; orange: 4320 cGy. Abbreviations: cGy, centigray; IMPT, intensity-modulated proton therapy; VMAT, volumetric-modulated arc therapy. Reproduced with permission from Chen et al [13].
Figure 2.
Figure 2.
Comparison of VMAT, PPBS, and VHEE planning. (a–d) Coronal images through PTV for the different modalities: (a) VMAT, (b) PPBS, (c) 100 MeV VHEE and (d) 200 MeV VHEE. (e) mean doses to the spinal cord, parotid glands, oral cavity, and brain stem, (f) dose volume histogram for the PTVs and brain stem. Abbreviations: PPBS, proton pencil-beam scanning; PTV, planning target volume; VHEE, very high energy electron; VMAT, volumetric-modulated arc therapy. Reproduced with permission from Schuler et al [74].

Similar articles

Cited by

References

    1. Albright JT, Topham AK, Reilly JS. Pediatric head and neck malignancies: US incidence and trends over 2 decades. Arch Otolaryngol Head Neck Surg. 2002;128:655–9. - PubMed
    1. Robison LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, Li FP, Meadows AT, Mulvihill JJ, Neglia JP, Nesbit ME, Packer RJ, Potter JD, Sklar CA, Smith MA, Stovall M, Strong LC, Yasui Y, Zeltzer LK. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002;38:229–39. - PubMed
    1. Hein PA, Gladstone DJ, Bellerive MR, Hug EB. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors. Int J Radiat Oncol Biol Phys. 2005;62:1540–8. - PubMed
    1. McDonald MW, Esiashvili N, George BA, Katzenstein HM, Olson TA, Rapkin B, Marcus RB., Jr Intensity-modulated radiotherapy with use of cone-down boost for pediatric head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2008;72:884–91. - PubMed
    1. Wolden SL, Wexler LH, Kraus DH, Laquaglia MP, Lis E, Meyers PA. Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2005;61:1432–8. - PubMed

LinkOut - more resources